https://www.selleckchem.com/pr....oducts/bay-2416964.h
ypothermia during partial nephrectomy does not preserve kidney function in patients with normal or mildly impaired renal function. Patients with bacillus Calmette-Guérin-unresponsive carcinoma in situ are treated with radical cystectomy or salvage intravesical chemotherapy. Recently, pembrolizumab was approved for bacillus Calmette-Guérin-unresponsive carcinoma in situ. We used a decision-analytic Markov model to compare pembrolizumab, salvage intravesical chemotherapy (with gemcitabine-docetaxel induction+monthly maintenance) and r
Like
Comment
Share
